UPDATED DATA: UK Myocarditis Authors Stratify by Sex for Men under 40- Vax vs Virus
What this video covers
In this December 2021 video, Prasad discusses an update to a major UK study of myocarditis after COVID-19 vaccination and infection — the Nature Medicine analysis by Patone and colleagues using England’s national health data. The key development, in Prasad’s telling, is that the authors released additional data stratified by sex, allowing a clearer comparison of myocarditis risk from vaccination versus from infection in men under 40.
Prasad argues the stratified data sharpened his core point: for young men, the myocarditis risk after a second dose of Moderna was comparable to — and in some age bands, in his reading, exceeded — the myocarditis risk from SARS-CoV-2 infection itself. He presents this as undermining the standard public-health claim that infection always posed the greater cardiac risk, and as further evidence that universal vaccination recommendations for young men were not supported by the data.
The chronicle notes the interpretive disputes around this study. The authors themselves cautioned that their analysis had limitations — including the difficulty of comparing vaccine-associated and infection-associated myocarditis, which differ in clinical course — and public-health agencies continued to recommend vaccination for young men while updating safety information. Prasad’s reading was one interpretation among several; other researchers emphasized that infection carried broader risks beyond myocarditis and that the absolute risk from either source was small. Prasad’s video treats the stratification as a vindication of his risk-stratified approach to vaccine policy.
Key points
- Prasad reviews updated UK data (Patone et al., Nature Medicine) now stratified by sex for men under 40.
- According to Prasad’s reading, myocarditis risk after a second Moderna dose in young men rivaled or exceeded the risk from infection itself.
- He argues the stratified data undermines the claim that infection always posed the greater cardiac risk for young men.
- Prasad presents the findings as evidence that universal vaccination recommendations for young men lacked data support.
- The chronicle notes the study’s authors cautioned about comparing vaccine- and infection-associated myocarditis, which differ clinically.
- Other researchers emphasized infection’s broader risks beyond myocarditis and the small absolute risk from either source — context Prasad’s video largely sets aside.